Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for AVCR.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
March 31, 2026 -462.5%
December 31, 2025 -2.82K%
September 30, 2025 -1.01K%
June 30, 2025 -1.60K%
March 31, 2025 -17.83%
December 31, 2024 -50.14%
September 30, 2024 -14.98%
June 30, 2024 5.17%
March 31, 2024 14.99%
December 31, 2023 4.40%
September 30, 2023 -29.90%
June 30, 2023 -51.86%
March 31, 2023 -30.44%
December 31, 2022 -25.05%
September 30, 2022 -31.53%
June 30, 2022 -117.7%
March 31, 2022 -434.9%
December 31, 2021 -593.5%
September 30, 2021 -585.0%
June 30, 2021 -7.03K%
March 31, 2021 -9.41K%
December 31, 2020 -6.65K%
September 30, 2020 -2.55K%
June 30, 2020 -2.33K%
March 31, 2020 -2.75K%
Date Value
September 30, 2019 -6.04K%
June 30, 2019 -6.22K%
March 31, 2019 -8.21K%
December 31, 2018
September 30, 2018
June 30, 2018 -501.1%
March 31, 2018 -441.0%
December 31, 2017 -883.6%
September 30, 2017 -482.3%
June 30, 2017 -233.0%
March 31, 2017 -599.8%
December 31, 2016 -8.88K%
September 30, 2016 -78.69%
June 30, 2016 -444.6%
March 31, 2016 -150.5%
June 30, 2015 -20.49K%
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
KDA Group, Inc. -1.01K%
HLS Therapeutics, Inc. -6.95%
Spectral Medical, Inc. 53.30%
Resverlogix Corp. --
Theratechnologies, Inc. --